Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Cynthia Rudin, PhD, is a highly regarded computer scientist who’s been eyeing the advance of artificial intelligence into society with equal parts enthusiasm and concern.
By now it’s a difficult-to-dispute likelihood: AI won’t replace doctors making diagnoses, but doctors who use AI will displace doctors who don’t use AI. The hypothesis gets a fresh airing out from the vantage point of the general public.
In an effort to attract Hispanic patients, MyTelemedicine, a national telemedicine provider, is launching a comprehensive version of their service in Spanish.
eHealth can make a significant impact in care delivery for those in rural areas. For those in Africa, eHealth makes the world of a difference for the millions of patients without healthcare.
The danger of falling for a senior is a real threat, especially for those who are alone for extended periods of time. Blue Willow Systems is changing the way older individuals are monitored with wearable technology that improves patient monitoring.
Inhibikase Therapeutics has received FDA approval to begin two proof-of-principle trials to use its kinase inhibitor strategy as a possible treatment for Parkinson's disease.
The nation’s largest for-profit health system is taking extra measures to make sure its patients don’t contract MRSA, which the CDC says killed more than 9,000 patients who contracted the infection in healthcare settings in 2014 alone.
Ablative Solutions has received approval from the FDA for the continuation of testing on its Peregrine System Kit for catheter-based renal denervation with precision delivery of alcohol treatment for hypertension.
